mm-120
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 17, 2021 (NCT05200936)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05407064 | Phase 2 | Aug 27, 2022 | Mind Medicine, Inc. |
| NCT05200936 | Phase 2 | Dec 17, 2021 | Maastricht University, Mind Medicine, Inc., University of Basel |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mind Medicine, Inc. | For profit | 2 | 2 | 1 | 2021 |
| Maastricht University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Basel | Academic/Hospital | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1